A technical appraisal of guidelines for the management of skin rash in patients on chemotherapy and targeted therapy
Abstract Background Skin rash remains one of the most prevalent and troublesome clinical problems experienced by patients on chemotherapy and targeted therapy. To ensure high-quality care, guidelines are seen as the best guidance. Considering the quality of guidelines varies greatly, a systematical...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2019-10-01
|
Series: | BMC Health Services Research |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12913-019-4539-6 |
id |
doaj-86fc346b6b4b45b09495848866adeddd |
---|---|
record_format |
Article |
spelling |
doaj-86fc346b6b4b45b09495848866adeddd2020-11-25T03:57:46ZengBMCBMC Health Services Research1472-69632019-10-011911910.1186/s12913-019-4539-6A technical appraisal of guidelines for the management of skin rash in patients on chemotherapy and targeted therapyFangyuan Zhang0Sumei Lv1Yating Feng2Xuan Yang3Wanmin Qiang4Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for CancerForth Hospital of Hebei Medical UniversityThe First Affiliated Hospital of Zhengzhou UniversityTianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for CancerTianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for CancerAbstract Background Skin rash remains one of the most prevalent and troublesome clinical problems experienced by patients on chemotherapy and targeted therapy. To ensure high-quality care, guidelines are seen as the best guidance. Considering the quality of guidelines varies greatly, a systematical appraisal of the methodological quality of guidelines for the management of skin rash in patients on chemotherapeutic drugs and targeted anticancer therapies was undertaken, in order to identify appropriate ones for healthcare professionals. Methods A systematic search of databases and Internet was conducted to obtain pertinent guidelines. Two reviewers independently assessed the eligibility of guidelines according to the inclusion criteria. Then the guidelines included were appraised by three researchers with the methodological quality of eligible guideline using Appraisal of Guidelines for Research and Evaluation II (AGREEII). Results Totally nineteen guidelines met the inclusion criteria. The quality ranged from good to acceptable in scope and purpose (mean: 78.80%, range: 66.67–94.44%) and clarity of presentation domains (mean: 85.38%, 75.00–91.67%), but not in stakeholder involvement (mean: 50.15%, range: 36.11–75.00%), rigor of development (mean: 23.65%, range: 6.25–70.83%), applicability (mean: 23.96%, range: 4.17–52.08%), and editorial independence domains (mean: 45.18%, range: 0.00–87.50%). Overall, two guidelines were classified as “recommended”. Conclusions Only two guidelines were recommended to manage skin rash in patients on chemotherapy and targeted therapies, most guidelines issued were of low to moderate quality. Thus, more attention should be paid to the methodological quality of guideline development in this field.http://link.springer.com/article/10.1186/s12913-019-4539-6ChemotherapyTargeted therapyRashGuidelinesAGREE |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Fangyuan Zhang Sumei Lv Yating Feng Xuan Yang Wanmin Qiang |
spellingShingle |
Fangyuan Zhang Sumei Lv Yating Feng Xuan Yang Wanmin Qiang A technical appraisal of guidelines for the management of skin rash in patients on chemotherapy and targeted therapy BMC Health Services Research Chemotherapy Targeted therapy Rash Guidelines AGREE |
author_facet |
Fangyuan Zhang Sumei Lv Yating Feng Xuan Yang Wanmin Qiang |
author_sort |
Fangyuan Zhang |
title |
A technical appraisal of guidelines for the management of skin rash in patients on chemotherapy and targeted therapy |
title_short |
A technical appraisal of guidelines for the management of skin rash in patients on chemotherapy and targeted therapy |
title_full |
A technical appraisal of guidelines for the management of skin rash in patients on chemotherapy and targeted therapy |
title_fullStr |
A technical appraisal of guidelines for the management of skin rash in patients on chemotherapy and targeted therapy |
title_full_unstemmed |
A technical appraisal of guidelines for the management of skin rash in patients on chemotherapy and targeted therapy |
title_sort |
technical appraisal of guidelines for the management of skin rash in patients on chemotherapy and targeted therapy |
publisher |
BMC |
series |
BMC Health Services Research |
issn |
1472-6963 |
publishDate |
2019-10-01 |
description |
Abstract Background Skin rash remains one of the most prevalent and troublesome clinical problems experienced by patients on chemotherapy and targeted therapy. To ensure high-quality care, guidelines are seen as the best guidance. Considering the quality of guidelines varies greatly, a systematical appraisal of the methodological quality of guidelines for the management of skin rash in patients on chemotherapeutic drugs and targeted anticancer therapies was undertaken, in order to identify appropriate ones for healthcare professionals. Methods A systematic search of databases and Internet was conducted to obtain pertinent guidelines. Two reviewers independently assessed the eligibility of guidelines according to the inclusion criteria. Then the guidelines included were appraised by three researchers with the methodological quality of eligible guideline using Appraisal of Guidelines for Research and Evaluation II (AGREEII). Results Totally nineteen guidelines met the inclusion criteria. The quality ranged from good to acceptable in scope and purpose (mean: 78.80%, range: 66.67–94.44%) and clarity of presentation domains (mean: 85.38%, 75.00–91.67%), but not in stakeholder involvement (mean: 50.15%, range: 36.11–75.00%), rigor of development (mean: 23.65%, range: 6.25–70.83%), applicability (mean: 23.96%, range: 4.17–52.08%), and editorial independence domains (mean: 45.18%, range: 0.00–87.50%). Overall, two guidelines were classified as “recommended”. Conclusions Only two guidelines were recommended to manage skin rash in patients on chemotherapy and targeted therapies, most guidelines issued were of low to moderate quality. Thus, more attention should be paid to the methodological quality of guideline development in this field. |
topic |
Chemotherapy Targeted therapy Rash Guidelines AGREE |
url |
http://link.springer.com/article/10.1186/s12913-019-4539-6 |
work_keys_str_mv |
AT fangyuanzhang atechnicalappraisalofguidelinesforthemanagementofskinrashinpatientsonchemotherapyandtargetedtherapy AT sumeilv atechnicalappraisalofguidelinesforthemanagementofskinrashinpatientsonchemotherapyandtargetedtherapy AT yatingfeng atechnicalappraisalofguidelinesforthemanagementofskinrashinpatientsonchemotherapyandtargetedtherapy AT xuanyang atechnicalappraisalofguidelinesforthemanagementofskinrashinpatientsonchemotherapyandtargetedtherapy AT wanminqiang atechnicalappraisalofguidelinesforthemanagementofskinrashinpatientsonchemotherapyandtargetedtherapy AT fangyuanzhang technicalappraisalofguidelinesforthemanagementofskinrashinpatientsonchemotherapyandtargetedtherapy AT sumeilv technicalappraisalofguidelinesforthemanagementofskinrashinpatientsonchemotherapyandtargetedtherapy AT yatingfeng technicalappraisalofguidelinesforthemanagementofskinrashinpatientsonchemotherapyandtargetedtherapy AT xuanyang technicalappraisalofguidelinesforthemanagementofskinrashinpatientsonchemotherapyandtargetedtherapy AT wanminqiang technicalappraisalofguidelinesforthemanagementofskinrashinpatientsonchemotherapyandtargetedtherapy |
_version_ |
1724458742126215168 |